Dual-task Training to Prevent Cognitive Decline in Community-dwelling Older Adults: A Pilot Pragmatic RCT

December 3, 2024 updated by: Dr. Pui-Hing Chau, The University of Hong Kong

Dual-task Training to Prevent Cognitive Decline in Community-dwelling Older Adults: A Pilot Pragmatic Randomised Controlled Trial

Objectives:

This study aims to explore the feasibility and acceptance of group-based dual-task training for prevention of cognitive decline in a pragmatic setting for community-dwelling older adults.

The primary objective is to assess recruitment rate, attendance rate, retention rate and satisfaction rate of participants.

Study design and participants:

This is a pilot pragmatic RCT with waitlist control. First, a co-design approach will be adopted to develop the intervention with the older adults. Then, about six participating community centres will nominate staff or volunteer to receive the training in order to lead the intervention. Informed consent will be sought from the participants and baseline assessment will be conducted. The participants will be randomly allocated to the intervention and control groups in 1:1 ratio using block randomisation with varying block size. At the end of the study, one representative of each participating centre will be invited to provide qualitative feedback.

Measurements:

The primary outcomes are the feasibility outcomes, namely the recruitment rate, attendance rate, the retention rate, and satisfaction rate of participants. Secondary outcomes include completion rate of the interventionist, time to recruit target sample size, factors influencing older adults' decision to participate and staff of the community centre to organise the activity, subjective memory complaints, working memory, executive function, and cognitive status of participants. A structured questionnaire will be used to collect quantitative outcomes related to effects and satisfaction. Qualitative feedback from representatives of the elderly community centres will be collected according to a semi-structured interview guide.

Expected results: The intervention is feasible and highly accepted by the participants and staff of the community centres. Potential effect-related outcomes are to be demonstrated.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

93

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Pui Hing Chau, PhD
  • Phone Number: 3917 6626
  • Email: phpchau@hku.hk

Study Locations

      • Hong Kong, Hong Kong
        • Recruiting
        • Community centre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

(i) aged 65 years and above,

(ii) eligible to enrol in activities organised by the community centres,

(iii) no communication problems,

(iv) able to understand and follow instructions,

(v) able to read and write Chinese.

Exclusion Criteria:

contraindications to chair-based or stepping exercises.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Assigned intervention
The intervention group will start 6 week dual-task invention immediately after baseline.
Participants will receive a one-hour face-to-face group-based dual-task training session twice a week for 6 weeks. Training included cognitive components and physical components to be conducted simultaneously.
Other: Assigned waitlist control
The control group will start 6 week dual-task invention after the follow-up assessment 6 weeks after baseline.
Participants will receive a one-hour face-to-face group-based dual-task training session twice a week for 6 weeks. Training included cognitive components and physical components to be conducted simultaneously.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate
Time Frame: After baseline, before randomization
Recruitment rate is defined as the number of participants agreed to join the study before randomization divided by the number of potential participants who completed recruitment briefing.
After baseline, before randomization
Attendance rate
Time Frame: 6 weeks after baseline for intervention group, 12 weeks after baseline for waitlist control group.
Attendance rate is defined as the number of attended intervention sessions collected in attendance log divided by the number of planned intervention sessions.
6 weeks after baseline for intervention group, 12 weeks after baseline for waitlist control group.
Retention rate
Time Frame: 6 weeks after baseline for intervention group, 12 weeks after baseline for waitlist control group.
Retention rate is defined as the number of participants completing the post-intervention assessment divided by the number of participants at baseline.
6 weeks after baseline for intervention group, 12 weeks after baseline for waitlist control group.
Satisfaction rate
Time Frame: 6 weeks after baseline for intervention group, 12 weeks after baseline for waitlist control group.
Satisfaction to the project will be measured by a question using 5-point Likert scale (very satisfactory to very unsatisfactory). Satisfaction rate is defined as the number of participants rating the intervention a score of ≥4 out of 5 divided by the number of participants started intervention.
6 weeks after baseline for intervention group, 12 weeks after baseline for waitlist control group.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Completion rate of the interventionist
Time Frame: End of study, up to 2 years
The number of nominated staff/volunteers considered as completing the project divided by the total number of nominated staff/volunteers
End of study, up to 2 years
Time to recruit target sample size
Time Frame: Before baseline
The time needed to recruit target sample size is defined as the time taken to recruit required sample size in each centre.
Before baseline
Factors influencing older adults' decision to participate and staff of the community centre to organise the activity
Time Frame: At the end of recruitment briefing, before baseline
Reasons of the older adults and staff of the community centres for joining or not joining the study
At the end of recruitment briefing, before baseline
Change from baseline subjective memory complaints at 6 weeks
Time Frame: 6 weeks after baseline
Subjective memory complaints will be measured by the 27-item Memory Inventory in Chinese (Lui et al., 2006). Participants response on the frequency of complaints related to daily living in the past month, using 0 (none) to 4 (continuously). The scale ranges from 0 to 108, higher score indicates more memory complaints.
6 weeks after baseline
Change from baseline subjective memory complaints at 12 weeks
Time Frame: 12 weeks after baseline, only for waitlist control group
Subjective memory complaints will be measured by the 27-item Memory Inventory in Chinese (Lui et al., 2006). Participants response on the frequency of complaints related to daily living in the past month, using 0 (none) to 4 (continuously). The scale ranges from 0 to 108, higher score indicates more memory complaints.
12 weeks after baseline, only for waitlist control group
Change from baseline working memory at 6 weeks
Time Frame: 6 weeks after baseline
Working memory will be measured by Digit Span Test (Leung et al., 2011). The participants will repeat the digits series which are gradually longer. In both the forward and the backward test, the longer the series, the better the condition.
6 weeks after baseline
Change from baseline working memory at 12 weeks
Time Frame: 12 weeks after baseline, only for waitlist control group
Working memory will be measured by Digit Span Test (Leung et al., 2011). The participants will repeat the digits series which are gradually longer. In both the forward and the backward test, the longer the series, the better the condition.
12 weeks after baseline, only for waitlist control group
Change from baseline executive function at 6 weeks
Time Frame: 6 weeks after baseline
Executive function will be measured by Chinese version of the Victoria Stroop Test (Lee and Chan, 2000). The completion time and number of errors that the participants made in naming the colour in the presence of different stimuli (number dots, words unrelated to color, words related to color) will be recorded, with more time and errors as worse condition.
6 weeks after baseline
Change from baseline executive function at 12 weeks
Time Frame: 12 weeks after baseline, only for waitlist control group
Executive function will be measured by Chinese version of the Victoria Stroop Test (Lee and Chan, 2000). The completion time and number of errors that the participants made in naming the colour in the presence of different stimuli (number dots, words unrelated to color, words related to color) will be recorded, with more time and errors as worse condition.
12 weeks after baseline, only for waitlist control group
Change from baseline cognitive status at 6 weeks
Time Frame: 6 weeks after baseline
Cognitive status will be measured by the Montreal Cognitive Assessment 5-Minutes (Hong Kong Version) (HK-MoCA 5-Min) protocol. The validated assessment test covers four domains: attention, executive functions/language, orientation, and memory (Yeung et al., 2014). The total score ranges from 0 to 30; a higher score indicates better cognitive status.
6 weeks after baseline
Change from baseline cognitive status at 12 weeks
Time Frame: 12 weeks after baseline, only for waitlist control group
Cognitive status will be measured by the Montreal Cognitive Assessment 5-Minutes (Hong Kong Version) (HK-MoCA 5-Min) protocol. The validated assessment test covers four domains: attention, executive functions/language, orientation, and memory (Yeung et al., 2014). The total score ranges from 0 to 30; a higher score indicates better cognitive status.
12 weeks after baseline, only for waitlist control group
Qualitative feedback
Time Frame: At the end of the study, up to 2 years
Qualitative feedback on facilitators and barriers of organising the activity will be collected from one representative of each participating centre by semi-structured interview.
At the end of the study, up to 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pui Hing Chau, PhD, School of Nursing, The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 21, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

October 11, 2024

First Submitted That Met QC Criteria

October 16, 2024

First Posted (Actual)

October 18, 2024

Study Record Updates

Last Update Posted (Estimated)

December 6, 2024

Last Update Submitted That Met QC Criteria

December 3, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Community-dwelling Seniors

Clinical Trials on Dual-task training

Subscribe